[-] Show simple item record

dc.contributor.authorElbehri, Azizeng
dc.date.issued2005eng
dc.descriptionIncludes bibliographical references.eng
dc.description.abstractBiopharming (using crops as drug-producing bioreactors) offers tremendous economic and health benefits stimulated by improving biotechnology methods. However, these benefits must be weighed against the potential risks to the food supply system and the costs of containing pharma crops to meet zero-tolerance contamination requirements. A combination of strong and adaptable regulatory oversight with technological innovations is required to achieve the twin goals of capturing the benefits of biopharming and safeguarding the food system and the environment. This paper examines the demand pull driving biopharming and the risk and liabilities to agriculture and reviews the regulatory and technological responses to the containment challenge faced by the food industry.eng
dc.identifier.citationAgBioForum, 8(1) 2005: 18-25.eng
dc.identifier.issn1522-936Xeng
dc.identifier.urihttp://hdl.handle.net/10355/125eng
dc.languageEnglisheng
dc.publisherAgBioForumeng
dc.relation.ispartofcollectionAgBioForum, vol. 8, no. 1 (2005)eng
dc.subjectplant-made pharmaceuticalseng
dc.subjecttransgenic cropseng
dc.subjectbiotechnology regulationseng
dc.subjectbiopharmingeng
dc.subject.lcshPlant genetic engineeringeng
dc.subject.lcshTransgenic plantseng
dc.subject.lcshPlant biotechnologyeng
dc.titleBiopharming and the Food System: Examining the Potential Benefits and Riskseng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record